Pulmonary Drug Delivery Systems Market Report 2022: Improved Patient Compliance and Ease of Use Drives Adoption
December 16, 2022 07:33 ET
|
Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "Pulmonary Drug Delivery Systems: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report will...
Global Respiratory Disease Partnering Deal Trends, Players and Financials Report 2022: Access to Available Deals and Contract Documents for Over 1000 Deals
December 05, 2022 07:38 ET
|
Research and Markets
Dublin, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Respiratory Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.The Global...
Outlook on the Tuberculosis Therapeutics Market in Vietnam to 2028 - Rising Government Measures and Growing Public Awareness of Communicable Illnesses are Driving Growth
September 28, 2022 06:43 ET
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Vietnam Tuberculosis Therapeutics Market, By Disease Type (Active Tuberculosis v/s Latent Tuberculosis), By Therapy (First Line Therapy v/s Second...
Global Tuberculosis Diagnosis and Treatment Market Report (2022 to 2028) - Key Players Include Otsuka Pharmaceuticals, Abbott Laboratories and Thermo Fisher Scientific
September 15, 2022 07:48 ET
|
Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Tuberculosis Diagnosis and Treatment Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global tuberculosis...
Europe Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, Shionogi & Co, AstraZeneca & Others
August 11, 2022 05:03 ET
|
Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Europe Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
LAMEA Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, AstraZeneca, Bristol Myers Squibb & Others
August 04, 2022 04:38 ET
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
Global Cystic Fibrosis Market Report 2022-2030 - Expanding Therapeutic Options is Expected to Drive Market Growth
August 03, 2022 08:03 ET
|
Research and Markets
Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...
Sarcoidosis Market and Epidemiology Report 2022-2032: Key Players, Developments and Opportunities
June 28, 2022 06:33 ET
|
Research and Markets
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Sarcoidosis - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering. Report Highlights ...
Middle East Respiratory Syndrome Coronavirus S Protein Drugs Report 2022: Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
June 13, 2022 04:43 ET
|
Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Middle East Respiratory Syndrome coronavirus S Protein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...
Alpha-1 Antitrypsin Deficiency Market Research Report 2022: Unmet Needs and Opportunities, Treatment Options, Pipeline Assessment, R&D Strategies, Outlook
June 10, 2022 07:48 ET
|
Research and Markets
Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical...